Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis Volume 9, 2008 - Issue 4
Journal homepage
63
Views
4
CrossRef citations to date
0
Altmetric
COMMENTARY

Commentary on ‘A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS’

Jeremy M. Shefner Department of Neurology, SUNY Upstate Medical University, , Syracuse, New York, USACorrespondence[email protected]
&
P. Nigel Leigh Department of Clinical Neuroscience, MRC Centre for Neurodegeneration Research, King's College London, Institute of Psychiatry, London, UK
Pages 254-256 | Received 08 May 2008, Published online: 10 Jul 2009

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Paul H. Gordon, Ying-Kuen Cheung, Bruce Levin, Howard Andrews & Hiroshi Mitsumoto. (2009) Response to commentary on a novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS. Amyotrophic Lateral Sclerosis 10:1, pages 61-61.
Read now

Articles from other publishers (3)

Jonathan S. Katz, Richard J. Barohn, Mazen M. Dimachkie & Hiroshi Mitsumoto. (2015) The Dilemma of the Clinical Trialist in Amyotrophic Lateral Sclerosis. Neurologic Clinics 33:4, pages 937-947.
Crossref
Hiroshi Mitsumoto, Benjamin R Brooks & Vincenzo Silani. (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?. The Lancet Neurology 13:11, pages 1127-1138.
Crossref
Zachary Simmons. (2009) Can we eliminate placebo in ALS clinical Trials?. Muscle & Nerve 39:6, pages 861-865.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.